Skip to main content
Premium Trial:

Request an Annual Quote

Reveal Biosciences to Use Affy ISH Tech With Image-Analysis Software

NEW YORK (GenomeWeb) – Reveal Biosciences has signed a deal to use Affymetrix's ViewRNA ISH products with tissue samples to provide RNA in situ hybridization staining, imaging, and quantification services in combination with its ImageDx image-analysis software, the companies announced today.

Specific terms of the deal were not disclosed.

"RNA in situ hybridization is fast becoming the method of choice for researchers wanting to validate established and novel biomarkers for translational and clinical research," Guy Afseth, marketing director for Affy's oncology portfolio, said in a statement.

"Our scientific expertise, combined with high-resolution imaging and our proprietary image analysis software … form a powerful platform for the localization and quantification of mRNA in tissue samples," Reveal Founder and CEO Claire Weston, added in the statement.

ViewRNA combines target-specific probe sets and branched DNA signal amplification for the detection of specific signals. ImageDx is designed to provide quantification data including percentage positivity and staining intensity over whole-slide images or single field or view images.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.